ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1

CUSIP: 00484MAA4

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Debt / NOTE 1.750% 6/1
Market price (% of par)
97.5%
Total 13F principal
$66,335,000
Principal change
-$2,450,000
Total reported market value
$64,373,000
Number of holders
9
Value change
+$2,460,433
Number of buys
2
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 00484MAA4?
CUSIP 00484MAA4 identifies 00484MAA4 - ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 as of Q1 2021

As of 31 Mar 2021, ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 was held by 9 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $66,335,000 in principal (par value) of the bond. The largest 9 bondholders included SOROS FUND MANAGEMENT LLC, WELLS FARGO & COMPANY/MN, Bruce & Co., Inc., Davidson Kempner Capital Management LP, GOLDMAN SACHS GROUP INC, UBS OCONNOR LLC, CREDIT SUISSE AG/, WESTWOOD HOLDINGS GROUP INC., and Continuum Advisory, LLC. This page lists 9 institutional bondholders reporting positions for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.